Autopsy report · NCT05365880

Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache

“Due to COVID-19 and both co-investigators have departed from the institution, we weren't able to enroll participants. Additionally, funding has lapse”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University of Utah

Sponsor type

University, hospital or other

Conditions

Headache; Stroke; Ischemic Stroke

Interventions

Liquid Lidocaine; Placebo

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer
  “COVID-19 pandemic, unable to enroll participants” (77% match in meaning)
• The Effective Parenting Program (EPP)
  “Covid-19 - unable to recruit any participants” (75% match in meaning)
• Foley Catheter Induction
  “unable to recruit participants due to COVID pandemic” (72% match in meaning)
• Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation
  “Because patient recruitment was affected by the COVID-19 pandemic, the study sponsor and funding partner halted enrollment at that time to meet contractual obligations” (72% match in meaning)
• Evaluating Emetine for Viral Outbreaks (EVOLVE)
  “The study was terminated due to insufficient participant enrollment resulting from a lower-than-expected number of COVID-19 cases” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.